Literature DB >> 15096133

Scleromyositis (scleroderma/polimyositis overlap) is an entity.

S Jablonska, M Blaszyk.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15096133     DOI： 10.1111/j.1468-3083.2004.00869.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN： 0926-9959            Impact factor:   6.166


× No keyword cloud information.
  4 in total

1.  Refractory dermatomyositis-systemic lupus erythematosus overlap syndrome and response to tofacitinib.

Authors:  Preston Williams; Benjamin McKinney
Journal:  Proc (Bayl Univ Med Cent)       Date:  2020-09-28

2.  Bilateral coxitis in scleroderma-polymyositis overlap syndrome.

Authors:  Khadija Berrada; Fatima Ezzahra Abourazzak; Ghita Sqalli Houssaini; Nadira Kadi; Latifa Tahiri; Kawthar Amrani; Zineb Khammar; Meriam Lahlou; Rhizlane Berrady; Samira Rabhi; Siham Tizniti; Wafaa Bono; Taoufik Harzy
Journal:  Eur J Rheumatol       Date:  2014-09-01

Review 3.  Myositis specific autoantibodies.

Authors:  Ira N Targoff
Journal:  Curr Rheumatol Rep       Date:  2006-06       Impact factor: 4.592

4.  Disease progression in systemic sclerosis-overlap syndrome is significantly different from limited and diffuse cutaneous systemic sclerosis.

Authors:  Pia Moinzadeh; Elisabeth Aberer; Keihan Ahmadi-Simab; Norbert Blank; Joerg H W Distler; Gerhard Fierlbeck; Ekkehard Genth; Claudia Guenther; Ruediger Hein; Joerg Henes; Lena Herich; Ilka Herrgott; Ina Koetter; Alexander Kreuter; Thomas Krieg; Kathrin Kuhr; Hanns-Martin Lorenz; Florian Meier; Inga Melchers; Hartwig Mensing; Ulf Mueller-Ladner; Christiane Pfeiffer; Gabriela Riemekasten; Miklós Sárdy; Marc Schmalzing; Cord Sunderkoetter; Laura Susok; Ingo H Tarner; Peter Vaith; Margitta Worm; Gottfried Wozel; Gabriele Zeidler; Nicolas Hunzelmann
Journal:  Ann Rheum Dis       Date:  2014-01-03       Impact factor: 19.103
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.